{"organizations": [], "uuid": "f841b72ff7296948187f5b6116981ec3f7355c41", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "in.reuters.com", "main_image": "https://s2.reutersmedia.net/resources/r/?d=20180420&i=OV8C8FZBF&w=1200&r=OV8C8FZBF&t=2", "site_section": "http://feeds.reuters.com/reuters/INVideoBusiness", "section_title": "Reuters Video: Business", "url": "https://in.reuters.com/video/2018/04/20/japans-takeda-takeover-bid-causes-invest?videoId=419558136", "country": "US", "domain_rank": 408, "title": "Japan's Takeda takeover bid causes investor headache", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-20T14:56:00.000+03:00", "replies_count": 0, "uuid": "f841b72ff7296948187f5b6116981ec3f7355c41"}, "author": "", "url": "https://in.reuters.com/video/2018/04/20/japans-takeda-takeover-bid-causes-invest?videoId=419558136", "ord_in_thread": 0, "title": "Japan's Takeda takeover bid causes investor headache", "locations": [], "entities": {"persons": [{"name": "takeda", "sentiment": "negative"}, {"name": "kate king", "sentiment": "none"}], "locations": [{"name": "japan", "sentiment": "none"}], "organizations": [{"name": "takeda", "sentiment": "negative"}, {"name": "takeda pharmaceutical", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}, {"name": "allergan", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Japan's Takeda takeover bid causes investor headache Friday, April 20, 2018 - 01:47 \nTakeda Pharmaceutical shares lost almost 5 percent of their value on Friday as investors fretted over the size of any deal the Japanese firm would have to make after London-listed drugmaker Shire rejected its latest $63 bln bid. As Kate King reports, Botox-maker Allergan has also pulled out of the bidding battle.   \nTakeda Pharmaceutical shares lost almost 5 percent of their value on Friday as investors fretted over the size of any deal the Japanese firm would have to make after London-listed drugmaker Shire rejected its latest $63 bln bid. As Kate King reports, Botox-maker Allergan has also pulled out of the bidding battle.  //reut.rs/2Hir87M", "external_links": [], "published": "2018-04-20T14:56:00.000+03:00", "crawled": "2018-04-20T15:43:21.021+03:00", "highlightTitle": ""}